tiprankstipranks

Ute Lassnig Insider Profile

4 Followers
Ute Lassnig, Director at Marinomed Biotech AG, holds ― shares in Marinomed Biotech AG (Ticker: DE:93Z).
tipranks
Ute  Lassnig

Ute Lassnig
Marinomed Biotech AG (93Z)
Director

Not Ranked
Ute Lassnig has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Ute Lassnig does not currently own shares as a corporate insider.
A breakdown of Ute Lassnig's holdings

Insider Roles

Marinomed Biotech AG
(93Z)
Director
Roles that Ute Lassnig holds in companies

Most Profitable Insider Trade

Stock:
Marinomed Biotech AG
(93Z)
Rating:Informative Buy
Date:Feb 06, 2019 - Feb 06, 2020
Return:+29.20%
The most profitable trade made by Ute Lassnig

Ute Lassnig's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Marinomed Biotech AG
Feb 22, 2019
Director
Uninformative Buy
49.98K
Success Rate for
93Z
1 out of 1 profitable transactions on
93Z
100%
Average Return for
93Z
Average return per transaction on
93Z
+29.20%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Feb 06, 2019
Informative Buy
€42.75K
-
€75.00
+29.20%
Feb 22, 2019
Uninformative Buy
€49.98K
-
€40.87
List of latest transactions for each holding click on a transaction to see Ute Lassnig's performance on stock

Ute Lassnig insider profile FAQ

What is the percentage of profitable transactions made by Ute Lassnig?
The percentage of profitable transactions made by Ute Lassnig is ―.
    What is the average return per transaction made by Ute Lassnig?
    The average return per transaction made by Ute Lassnig is ―.
      What stocks does Ute Lassnig hold?
      Ute Lassnig holds: DE:93Z stocks.
        What was Ute Lassnig’s latest transaction?
        Ute Lassnig latest transaction was an Uninformative Buy of €49.98K.
          What was Ute Lassnig's most profitable transaction?
          Ute Lassnig’s most profitable transaction was an Informative Buy of DE:93Z stock on February 6, 2019. The return on the trade was 29.20%.
            What is Ute Lassnig's role in Marinomed Biotech AG?
            Ute Lassnig's role in Marinomed Biotech AG is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.